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Summary
Osteoarthritis (OA) is not caused by a simple consequence of aging and cartilage degradation. Based on the conventional paradigm, OA has
been considered a degenerative joint disorder. However, the dominant clinical symptom has been characterized by a non-infectious chronic
inflammatory condition with infiltration of inflammatory cells in the synovial tissue or synovial fluid, especially in the early stage of the disease.
The inflammatory process appeared to develop degeneration of chondrocytes and/or formation of osteophytes. Immunohistochemical
staining of synovial tissue with OA in the early stage, suggests the presence of T-cell infiltration in the perivascular area, some of which were
CD4 positive T cells. Among the T cells, we identified the clonality of restricted TCR usage of Vâ chain by single strand conformation
polymorphism (SSCP) method on T-cell repertoire. Therefore we address the immune response in primary OA.
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Osteoarthritis (OA) is one of the most frequent rheumatic
diseases observed mainly in elderly people.1 The clinical
findings of an inflammatory process such as joint swelling
or synovial effusions in the affected joints are one of the
most common clinical features in primary OA. In contrast
with rheumatoid arthritis (RA), little attention has been paid
to the inflammatory process of OA. However, several lines
of evidence suggest the presence of inflammatory process,
such as increased serum C-reactive protein levels,2 the
presence of immune complexes in the superficial articular
cartilage,3 and infiltration of inflammatory cells in synovial
fluid. Moreover, pro-inflammatory or inflammatory media-
tors such as interleukin (IL)-1 and tumor necrosis factor Æ
(TNF-Æ), have been detected in synovial fluid. These
inflammatory mediators are suppressed by administration
of an IL-1 receptor antagonist.4 Moreover, pathological
findings of the OA synovium often show mild or moderate
lymphocytic infiltration in the perivascular area. Based on
these findings, we postulated T-cell mediated osteoarthritis
as an etiological concept for primary OA.Material and methods
The diagnosis of primary OA depends on clinical symp-
toms and X-ray findings. With informed consent, five syno-
vial samples were obtained from four patients with primary
OA in knee surgery (one bilateral). Peripheral blood was
also obtained from the patients. Frozen sections were
made from part of the synovial tissues and were stained401with anti-CD3 antibody (DAKO). Total RNA was prepared
from about 1 g of synovial tissues and from lymphocytes of
peripheral blood. Complementary DNA was synthesized
and amplified by PCR using primers encoding Vâ regions
(Vâ1–Vâ20) and Câ region of T-cell receptors (TCR). PCR
products were analyzed by the single strand conformation
polymorphism (SSCP) technique5 to confirm the clonal
diversity of the TCR use. Then, PCR products encoding
genes of TCR Vâ4, Vâ5, Vâ6, Vâ7, Vâ8 and Vâ9 chains in
each of the synovial samples were cloned using a TA
cloning kit (Invitrogen). About 20 plaques were randomly
picked and the TCR insert was sequenced.This work is supported by a grant from the Japan Rheumatism
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St. Marianna University School of Medicine.Fig. 1. Immunohistochemistry shows the moderate infiltration of
CD3 positive T cells in the synovium of OA.Results
Mild or moderate infiltration of CD3 positive T cells was
observed in all of the synovial tissues especially in the
perivascular area (Fig. 1). In the SSCP image, mono or
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genes, whereas almost all Vâ genes from PBL were
smeared (Fig. 2). From the results of SSCP, we chose
Vâ4–Vâ9 for further sequencing.
The sequences of TCR Vâ CDR3 regions were
analyzed. If at least two clones had an identical sequence,
we defined the clone as dominant. Several dominant
clones were found in each sample and common amino acid
motifs in the CDR3 regions (LRGS, LAGG, LQG, GTG,
GTS, GSA, QVG and TGG) were conserved in different
samples.Discussion
Oligoclonal expansion of T cells with highly conserved
amino acid motifs in the CDR3 regions was reported in the
synovial tissue of rheumatoid arthritis (RA)5 and juvenile
RA patients,6 the lacrimal gland7 and the kidney8 of
Sjo¨gren’s syndrome patients, and skin lesion of systemic
lupus erythematosus.9 These reports suggest that T-cell
mediated immune response to some antigens is present in
the target organs of autoimmune diseases.
In our present study, immunohistochemical analysis
showed the moderate lymphocyte infiltration with CD3
antigen, T-cell marker, in the synovium of OA patients, and
the usage of the TCR Vâ chain was deviated by SSCP
analysis. Sequencing analysis showed that several amino
acid motifs were frequently detected and some of them
were conserved in different patients. These results suggest
that an antigen-driven immune reaction clearly exists in the
synovium of OA patients. Although OA is not a disease with
a systemic immune disorder, the presence of a local
pro-inflammatory process is suggested as in organ-specificautoimmune diseases such as uveitis or demyelinated
encephalopathy. T-cell mediated OA, with chronic inflam-
matory conditions, might be responsible for chondrocyte
degeneration or hyaluronic acid degradation. Moreover, we
have been characterizing a part of the pathogenic peptides
which contribute to synovial T-cell activation (Tsuruha et al.,
unpublished data). Together with these findings, we postu-
late not only a novel paradigm for the pathogenesis of OA,
but also a new therapeutic strategy such as suppression of
T-cell activation with these pathogenic peptides.Fig. 2. A representative example of T-cell clonotype accumulation
in the synovium of a patient with osteoarthritis shown by PCR-
SSCP. TCR Vâ clonotype of articular infiltrating T cells and
peripheral blood lymphocytes (PBL) was analyzed by PCR-SSCP
method. Note the presence of several distinct bands for Vâ4, 5, 6,
7, 8, 9, 13, and 19 genes in synovial samples, whereas only a
smear was observed for genes in PBL. S, synovial tissue; P, PBL.References
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